Acadia Healthcare (NASDAQ:ACHC) Releases FY 2024 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) updated its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.350-3.450 for the period, compared to the consensus EPS estimate of 3.520. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.2 billion. Acadia Healthcare also updated its FY24 guidance to $3.35-$3.45 EPS.

Analyst Upgrades and Downgrades

Several research firms have commented on ACHC. Deutsche Bank Aktiengesellschaft increased their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Barclays dropped their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. KeyCorp assumed coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday, September 20th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and a consensus target price of $86.67.

Acadia Healthcare Stock Up 0.9 %

NASDAQ ACHC traded up $0.48 during trading hours on Wednesday, hitting $52.08. The company’s stock had a trading volume of 1,225,242 shares, compared to its average volume of 950,992. The company has a market capitalization of $4.83 billion, a PE ratio of -372.00, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52 week low of $50.20 and a 52 week high of $87.77. The company’s 50-day simple moving average is $67.15 and its two-hundred day simple moving average is $68.18.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. During the same period last year, the business earned $0.92 EPS. The business’s revenue was up 8.8% on a year-over-year basis. Research analysts anticipate that Acadia Healthcare will post 3.51 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.